Open company graph database — free web & API
Login

Sysmex Chile SpA

Sysmex チリ株式会社Alias
Ticker
—
Listed market
—
Country
Japan
Employees (consolidated)
11,457
Related companies
1
§01

Basic information

BASIC
Head office
1-5-1 Wakihama Kaigan-dori, Chuo-ku, Kobe-shi, Hyogo-ken 651-0073
Chief executive
Ishine Matsui
Capital
14,887,000,000 JPY (148 100 millionJPY)
Employees (non-consolidated)
3,400 people
Employees (consolidated)
11,457 people
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

44
Clinical productsResearch productsPhysical and chemical, non-clinical productsFlow cytometry for research and physical-chemical analysisNon-clinical blood tests and cell analysisDiagnostic instrumentsSurgical assistance robotCancer gene panel testBlood test systemServices & SupportAlzheimer's disease diagnosisCell measurement technologyProtein measurement technologyGenetic measurement technologyDiagnostics businessHematologyFlow cytometryUrine testingBiochemical testingBlood coagulation testingImmunological testingCancer gene testDrug susceptibility testICT solution CaresphereMedical robotics businessSurgical assistance robot systemEfforts toward dementiaAlzheimer's disease andDiscussion on cancer gene panel testDiscussion on inherited retinal dystrophy (IRD)Efforts toward antimicrobial resistance (AMR)Fundamentals of Specimen TestingSupporting Diagnostics! SysmexSpecimen testing businessDiagnostic and Testing ServicesRemote Surgery ServicesMedical Device Implementation, Operation Support, and Maintenance ServicesBlood testingSpecimen testingFlow Cytometry AnalysisCell analysisSales, Services & Supporthinotori™Operating Environment Improvement Services
§04

Related companies

1 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Sysmex Reagents America, Inc.
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

150 EVENTS

Taro Nakata departs for overseas inspection, having sought a new business pillar while at TOA Corporation (formerly TOA Special Electric Co., Ltd.), a leading manufacturer of amplification devicesSources

TOA Special Electric Co., Ltd. (now TOA Corporation) decides to enter the medical electronic device industry, establishes a new laboratory, and three engineers begin researchSources

CC-1001 successfully commercializes Japan’s first automatic blood cell counter (Automatic Blood Cell Counter CC-1001)Sources

Founder Taro Nakata announces the company’s stance of "selling counting results"Sources

MCC News Issue 1: Launch of Automatic Blood Cell Counter CC-1002; MCC News is distributed to hospital laboratories nationwide (MCC: Micro Cell Counter)Sources

First diagnostic reagent developed: dilution solution "Cell Kit" and hemolysin "Saponin-S"; released as the first diagnostic reagents by an electrical manufacturerSources

At the time, the ME Equipment Department of TOA Special Electric Co., Ltd. (now TOA Corporation) is established (ME = Medical Electronics)Sources

Basic Management Policy "Three Assurances" (current founding philosophy); establishes "Basic Principles of Company Management" summarizing fundamental management concepts and action guidelinesSources

TOA Medical Electronics Co., Ltd. is founded as a sales company for medical electronic devices manufactured by TOA Special Electric Co., Ltd. (now Sysmex Corporation)Sources

Cell Check-B: releases standard material "Cell Check™-B" containing specific cell counts to verify accurate blood cell measurement in laboratoriesSources

German Representative Office (Hamburg): acquires the medical electronic device development and manufacturing division of TOA Special Electric Co., Ltd. (now TOA Corporation) and establishes a new clinical laboratory equipment manufacturer; first overseas branch in GermanySources

Kakogawa Factory (Kakogawa City, Hyogo Prefecture): establishes Kakogawa Factory in Kakogawa City, Hyogo Prefecture, consolidating sales, development, production, and general affairs departmentsSources

Taro Nakaya’s passionate speech at the founding anniversary ceremony deeply resonated within the company, as he strongly instructed all employees that "quality is heart. It is the life of the company."Sources

Released the TU-100 "Simple Automatic Urine Analyzer TU-100," entering the urine testing field.Sources

Released the CC-710, Japan’s first fully automatic hematology analyzer (Fully Automatic Hematology Analyzer CC-710).Sources

Established an overseas office in the United States (San Francisco), marking the start of entry into the U.S. market.Sources

Birth of the Sysmex brand.Sources

Changed the product brand from "Toa" to "Sysmex."Sources

Held the first Sysmex Hematology Seminar.Sources

Released the CC-720, the world’s first fully automatic hematology analyzer equipped with an automatic sample feeder (sampler).Sources

Establishment of the U.S. subsidiary Toa Medical Electronics (USA) Inc. (now Sysmex America, Inc.)Sources

Establishment of local subsidiary in Europe (Hamburg, Germany) – TOA MEDICAL ELECTRONICS (DEUTSCHLAND) GMBH (now Sysmex Europe SE)Sources

Establishment of the European subsidiary Toa Medical Electronics (Deutschland) GmbH (now Sysmex Europe SE)Sources

Released the E Series, a multi-parameter automatic hematology analyzer that established the "Sysmex" brand overseas.Sources

Released the CA-100 Automatic Coagulation Analyzer.Sources

Released the CA-3000 Automatic Coagulation Analyzer, incorporating robotic engineering ideals to achieve random processing for each sample.Sources

Strengthening development structure in blood coagulation, immunology, and urinalysis – New Kobe factory at Nishinaga Industrial Park, research & development moved (Hyogo Prefecture, Kobe City / now Techno Park)Sources

Established a new Kobe factory in the Nishin Industrial Complex (Nishi-ku, Kobe) and relocated the R&D department (now Techno Park).Sources

Released the PAMIA-10 Immunoagglutination Analyzer, measuring trace proteins in serum using a proprietary immunoassay, entering the immunology field.Sources

Rei-zo Hashimoto appointed president – declared "world leadership in hematology within 10 years" and "new business revenue share over 40%"Sources

Rei-zo Hashimoto became president.Sources

Declared "to become a world leader in hematology within 10 years" and "to achieve a new business revenue composition ratio of over 40%".Sources

Released the R-1000 Automatic Reticulocyte Analyzer, the world’s first device capable of automatically measuring reticulocytes.Sources

Released the NE-8000 Multi-Parameter Automatic Hematology Analyzer, enabling simultaneous measurement of hematology counts and leukocyte differential, with comprehensive biohazard precautions.Sources

Moved headquarters to Chuo-ku, Kobe (Port Island), consolidating headquarters functions and sales & trade departments.Sources

Released the HS Series Comprehensive Hematology Test System, the world’s first fully automated system covering hematology counts, leukocyte differential, reticulocyte counts, and slide preparation.Sources

Released the UA-1000 Automatic Urine Analyzer, entering the urine sediment analysis field with an in-house developed product.Sources

First domestic diagnostic drug production plant established (Kōno City, Hyogo Prefecture); first overseas direct sales, service & support launched (UK) – establishment of first overseas sales subsidiary TOA MEDICAL ELECTRONICS (UK) LTD. (now Sysmex UK Limited)Sources

Established the Ono plant in Ono City, Hyogo Prefecture as the first domestic diagnostic drug production facility, relocating the diagnostic drug production divisionSources

Launched direct sales, service, and support overseas for the first time (United Kingdom)Sources

Establishment of the U.K. subsidiary Toa Medical Electronics (UK) Ltd. (now Sysmex UK Limited)Sources

Established Sysmex TMC Co., Ltd.Sources

Commenced diagnostic drug production overseas (Germany); established European production site in Nuremberg; established U.S. production site SYSMEX CORPORATION OF AMERICA (now Sysmex Reagents America, Inc.)Sources

Established the new Noimuster plant as a European diagnostic drug production siteSources

Establishment of the U.S. subsidiary Sysmex Corporation (now Sysmex Reagents America, Inc.)Sources

Initiated establishment of Asia-Pacific regional facilities – opened liaison office in SingaporeSources

Commenced development of Asia-Pacific facilities, opening a resident office in SingaporeSources

Accelerated expansion in blood coagulation testing – entered into sales partnership with Deid International (now Siemens Healthineers Diagnostics Co., Ltd.) for blood coagulation products; established supply & technical service system in China; founded joint venture Jiangnan Donghua Medical Electronics Co., Ltd. (now Jiangnan Hoshin Medical Electronics Co., Ltd.) in Jiangnan, ChinaSources

Listed on Osaka Stock Exchange Second Section; strengthened corporate structure through listing activities – later listed on Tokyo Stock Exchange Second Section (1996) and promoted to First Section of Osaka and Tokyo Stock Exchanges (2000)Sources

Established the German subsidiary Sysmex GmbH Deutschland (now Sysmex Deutschland GmbH) and entered into a business alliance with Dieid International (now Siemens Healthineers Diagnostics Ltd.) for the sale of coagulation productsSources

Held a press conference for the establishment of Zhennan Hishin Medical Electronics Co., Ltd. and set up a joint venture in China, Zhennan Dongya Medical Electronics Co., Ltd. (now Zhennan Hishin Medical Electronics Co., Ltd.)Sources

Obtained ISO 9001 certification, an international quality assurance standardSources

Released the SF-3000, a multi-parameter automated hematology analyzer that integrates semiconductor laser and flow cytometry technology, promoting the spread of white blood cell differential analyzers in small to medium-sized laboratoriesSources

Launched a clinical laboratory information systemSources

Released the UF-100, the world's first fully automated urinary sediment analyzer, and listed on the second section of the Osaka Stock ExchangeSources

Kazuhiko Ieji (now Chairman & Group CEO) appointed president – declared "aiming to become a distinctive global integrated manufacturer from a specialty maker"Sources

Listed on the second section of the Tokyo Stock Exchange; Chairman Kaji Kose (now Group CEO) became president and declared a shift from a specialty manufacturer to a globally distinctive integrated manufacturerSources

Establishment of the U.S. subsidiary Sysmex Infosystems America, Inc. (now Sysmex America, Inc.)Sources

Established Asia-Pacific regional headquarters SYSMEX SINGAPORE PTE LTD. (now Sysmex Asia Pacific Pte Ltd.) – strengthened global sales network through partnership with F. Hoffmann-La Roche (Switzerland) for hematology products; began diagnostic drug production in India – founded joint venture SYSMEX TRANSASIA BIO-MEDICALS PRIVATE LTD. (now Sysmex India Pvt. Ltd.) – renamed company to Sysmex Corporation on 30th anniversary and relocated headquartersSources

Established Sysmex Singapore Pte Ltd. (now Sysmex Asia Pacific Pte Ltd.) as the regional headquarters for the Asia-Pacific areaSources

Established the Malaysian subsidiary Sysmex (Malaysia) Sdn BhdSources

Entered a basic agreement for a global business alliance with F. Hoffmann-La Roche AG (Switzerland) for sales cooperation and joint R&DSources

Established the joint venture Sysmex Transasia Bio-Medicals Private Ltd. (now Sysmex India Pvt. Ltd.) in India for equipment and diagnostic drug production, obtaining ISO 13485 and EN 46001 certificationsSources

Renamed the headquarters to Sysmex Corporation (Hyogo Prefecture, Kobe City, Chuo Ward) and moved it to the eastern part of Kobe's new city centerSources

Established the Brazilian subsidiary Sysmex do Brasil Industria e Comercio Ltda.Sources

Released the XE-2100, a multi-parameter automated hematology analyzer, achieving labor-saving and efficiency improvements in laboratory operationsSources

Released "XE-2100" multi-parameter automated hematology analyzer – realized labor-saving and efficiency in testing operationsSources

Released the world's first peripheral vascular monitoring device, ASTRIM (Astrim)Sources

Establishment of Sysmex (Thailand) Co., Ltd. local subsidiary in ThailandSources

Establishment of customer support center in Hong Kong, local subsidiary Hoshin Meikang Hong Kong Ltd.Sources

Sysmex Shanghai Ltd. (Sysmex Medical Electronics (Shanghai) Co., Ltd.) Chinese local subsidiary Sysmex Medical Electronics (Shanghai) Co., Ltd. establishedSources

Established China regional headquarters Sysmex Shanghai Ltd. (Hoshin Medical Electronics (Shanghai) Co., Ltd.) – expanded global production system for stable diagnostic drug supply; began diagnostic drug production in Brazil and Singapore; started challenge in life science field – established central research institute within Techno Center (now Techno Park) in Kobe, Hyogo PrefectureSources

Start of diagnostic reagent production in BrazilSources

Promotion to First Section of Tokyo Stock Exchange and Osaka Stock Exchange marketsSources

Establishment of Sysmex France S.A.R.L. local subsidiary in France (now Sysmex France S.A.S.)Sources

Central Research Institute (Nishi-ku, Kobe City, Hyogo Prefecture)Sources

Opening of the central research institute at Technocenter (now Techno Park)Sources

Acquisition of ISO 14001 certification for environmental management system at Kakogawa plantSources

Establishment of joint venture Sysmex San Tung Co., Ltd. (now Sysmex Taiwan Co., Ltd.) in TaiwanSources

Start of diagnostic reagent production in SingaporeSources

Opening of Africa Service Center, a technical service hub in AfricaSources

Launch of PAMIA-40i, an immunoagglutination analyzer that reduces whole blood test time to about one-thirdSources

Capital participation in Delphic Medical Systems, renaming to Sysmex Delphic Limited (now Sysmex New Zealand Limited)Sources

Strengthened R&D for bio-diagnostic drug production – fully acquired International Reagents Co., Ltd. (absorbed in 2022)Sources

Establishment of PT. Sysmex Indonesia local subsidiary in IndonesiaSources

Full acquisition of International Reagents Co., Ltd. (absorbed in 2022)Sources

Development of a genetic test that detects the presence of cancer cell metastasis to lymph nodes within 15 minutesSources

Acquisition of R.A. Systems Co., Ltd. (now Sysmex RA Co., Ltd.)Sources

Commenced direct sales and direct service in the United StatesSources

Launch of direct sales and services in the United States; integration of Sysmex Corporation of America and Sysmex Infosystems America, Inc. to form Sysmex America, Inc.Sources

Chinese local subsidiary Sysmex Biotech (Wuxi) Co., Ltd. (Diagnostic Drug Second Factory) establishedSources

ASTRIM SU "Peripheral Blood Vessel Monitoring Device ASTRIM SU" wins Good Design AwardSources

Acquisition of Sysmex Delphic Limited (now Sysmex New Zealand Limited)Sources

Acquisition of CNA Co., Ltd. (now Sysmex CNA Co., Ltd.); technology for measuring embryonic stem cells receives Special Award at the 2004 National Invention AwardsSources

Establishment of Sysmex BMA Laboratory in Port Island, Kobe City, as part of the medical industry city initiativeSources

Establishment of local subsidiary Sysmex Polska Sp.z o.o. in PolandSources

Opening of Solution Center in Nishi-ku, Kobe City, Hyogo PrefectureSources

Stock splitSources

Establishment of Sysmex Women's Track and Field ClubSources

Launch of high-performance, compact multi-parameter automated hematology analyzer XS Series, following the measurement principles of the XE SeriesSources

Enabled rapid intraoperative lymph node metastasis testing for breast, colorectal, and gastric cancers, contributing to patient QOL improvement – first life science product "RD-100i" gene amplification detection system and related diagnostic drug "RinoAmp™BC" launched in EuropeSources

Established Sysmex Group corporate philosophy "Sysmex Way"Sources

Released "HISCL™-2000i" fully automated immunoassay analyzer, achieving high-sensitivity rapid testing with minimal sample volume through CLEIA (chemiluminescent enzyme immunoassay) developmentSources

Celebrating its 40th anniversary, the company unveiled a new corporate logo and opened the Core Research & Development Hub, Techno Park, in Kobe City, Hyogo Prefecture, with the concept "Creating and inheriting knowledge."Sources

Establishment of local subsidiary Sysmex RUS LLC in RussiaSources

Aiming to establish its position as the absolute global leader in hematology, the company globally launched the flagship model "Multi-parameter Automatic Blood Cell Analyzer XN™ Series" in the blood cell counting field, and released the new model "Fully Automatic Coagulation Analyzer CS-5100™" in the blood coagulation testing field, which improves processing capacity.Sources

Participation in the UN's Global CompactSources

Stock splitSources

Acquisition of the Biochemical Research Laboratory of Katakura Kogyo Co., Ltd.Sources

Global launch of new model multi-parameter automated hematology analyzer XN™ SeriesSources

Technology for leukocyte differential counting method and diagnostic reagents received the 2011 National Innovation Award (Innovation Prize) in JapanSources

Launch of new model fully automated coagulation analyzer CS-5100™Sources

Special sponsorship of the Kobe MarathonSources

Our hematology counting standard instrument adopted as a national standard in ChinaSources

Clinical testing system applying the design concept "Silent Design™" received the 2011 Good Design Gold AwardSources

Special sponsorship of the first local citizen marathon "Kobe Marathon 2011"Sources

Launch of contract testing service for early breast cancer recurrence risk researchSources

With a rapid 17-minute measurement and evolved functionality, the company contributed to test efficiency and the realization of pre-treatment testing by launching the new model "Fully Automatic Immunoassay Analyzer HISCL™-5000" in the immunohematology field.Sources

Launch of compact model multi-parameter hematology counter XP SeriesSources

Automation of rapid lymph node metastasis test for gastric cancerSources

Establishment of protein production facility in Nishi-ku, Kobe CitySources

Launch of new model fully automated immunoassay analyzer HISCL™-5000Sources

XN™-2000 and XN™ diagnostic reagents received the iF Product Design Award 2013 in GermanySources

Entering the medical robotics market, the company co-founded a marketing firm for medical robot development with Kawasaki Heavy Industries, Ltd. and MedicaRoid Co., Ltd., accelerating the expansion of a technology platform for personalized medicine. It acquired the German company Partec GmbH (now Sysmex Partec GmbH), a pioneer in FCM technology, and the German company Inostics GmbH (now Sysmex Inostics GmbH), which has technology for highly sensitive measurement of cancer genes in blood.Sources

Sysmex Business Support Co., Ltd. establishedSources

Sysmex Women's Track and Field Club moved to KobeSources

Korean local subsidiary Sysmex Korea Co., Ltd. establishedSources

"Development of a particle classification counting method in a multi-parameter automated hematology analyzer" received the Minister of Education, Culture, Sports, Science and Technology Award for Fiscal Year 2013Sources

Opening of Sysmex MoriSources

Opening of the U.S. R&D Center in the AmericasSources

Press conference for the establishment of Medicaid Co., Ltd.Sources

Establishment of Sysmex Turkey Diagnostik Sistemleri Ltd. Sti. in TurkeySources

Joint establishment of Kawasaki Heavy Industries Co., Ltd. and Medicaid Co., Ltd. for medical robot developmentSources

Acquisition of Partec Co., Ltd. (now Sysmex Partec GmbH) as a subsidiarySources

Acquisition of Inostics Co., Ltd. (now Sysmex Inostics GmbH) as a subsidiarySources

"ASTRIM FIT™ Health Monitoring Device" received the Good Design AwardSources

XN™-2000 and XN™ diagnostic reagents in the hematology field received the "German Design Award"Sources

Successful development of the first practical liver fibrosis test using a glycoconjugate marker "HISCL™ M2BPGi™ diagnostic reagent"Sources

Entering the contract genetic testing business, the company invested in RIKEN Genesis Co., Ltd. to advance the genetic testing industry (acquired as a subsidiary in 2016).Sources

Stock splitSources

Sales of Sysmex-branded blood coagulation test-related products began in the U.S. and EU countriesSources

"Development of a urine sample analysis method useful for early disease detection" received the 2024 Minister of Education, Culture, Sports, Science and Technology Award for Science and TechnologySources

"Rapid Antimicrobial Susceptibility Testing System PA-100 AST System" received the UK’s largest science award "Longitude Prize on AMR"Sources

Establishment of a diagnostic reagent and equipment production base in IndiaSources

Establishment of a diagnostic reagent and equipment production base in Gujarat, IndiaSources

Signed a global alliance agreement with KIAGEN Co., Ltd. in the genetic testing fieldSources

First in the industry, introduced a horizontal cycle container for diagnostic reagents and began sales in JapanSources

Relocation and expansion of Sysmex RA Co., Ltd.'s factory in Shiojiri City, Nagano PrefectureSources

Establishment of Sysmex East Africa Ltd., local subsidiary in KenyaSources

Establishment of Sysmex Greece I.K.E., local subsidiary in GreeceSources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑